"Est formulado con el mismo principio activo, mismas concentraciones, mismos excipientes y misma va de administracin que el medicamento anteriormente autorizado
Insulin Sensitivity: Research indicates that MOTS-c may improve insulin sensitivity, a key factor in metabolic health
Pharmacokinetic studies of several bioactive compounds have demonstrated limited oral bioavailability, rapid metabolism, extensive first-pass hepatic clearance, and low systemic exposure
There is a huuuuuuuge difference between loosing 19 kg of fat and 1kg of lean tissue, and loosing 3 kg of fat and 17kg of muscles
In studies, most nausea, diarrhea, and vomiting occurred when people increased their dose but the effects generally decreased over time